HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.
Cancer shared this article with you from Inoreader
CONCLUSIONS: Serum HE4 and CA125 improved on existing methods for risk stratification of endometrioid carcinomas and warrant further investigation. PMID: 33213897 [PubMed - as supplied by publisher] (Source: Gynecologic Oncology)
No comments:
Post a Comment